By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Z-drug hypnotic > Zolpidem

Zolpidem

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|622 words

Zolpidem

What is Zolpidem?

Zolpidem is a prescription sleep medication belonging to a class of drugs called Z-drug hypnotics, which are chemically distinct from benzodiazepines but work on similar brain receptors. It is primarily prescribed for the short-term treatment of insomnia, specifically helping people fall asleep faster. Zolpidem is designed to provide effective sleep induction with a relatively short duration of action to minimize next-day drowsiness.

Uses

Zolpidem has several approved therapeutic applications:

  • Short-term insomnia treatment: The primary use for helping patients who have difficulty falling asleep, typically prescribed for 7-10 days
  • Sleep initiation disorders: Specifically targets problems with sleep onset rather than sleep maintenance
  • Situational sleep disruption: May be prescribed for temporary sleep difficulties due to stress, travel, or schedule changes
  • Extended-release formulations: Some versions help with both falling asleep and staying asleep throughout the night

How it works

Zolpidem works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and sleep in the brain. It selectively binds to specific GABA receptors, particularly those containing the alpha-1 subunit, which are associated with sedation and sleep induction. This selective binding is thought to provide sleep benefits while potentially reducing some side effects compared to less selective sleep medications.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Drowsiness or dizziness the next day
  • Headache
  • Nausea or stomach upset
  • Muscle weakness
  • Coordination problems
  • Memory problems or amnesia
  • Unusual dreams
  • Dry mouth

Serious side effects requiring immediate medical attention:

  • Complex sleep behaviors (sleepwalking, sleep-driving, sleep-eating)
  • Severe allergic reactions including swelling of face, lips, or throat
  • Severe depression or suicidal thoughts
  • Hallucinations or confusion
  • Severe memory loss or amnesia

Warnings and precautions

  • Dependency risk: Zolpidem can be habit-forming and should only be used for short periods as directed by a healthcare provider
  • Complex sleep behaviors: Patients may engage in activities while not fully awake, including driving, which can be dangerous
  • Pregnancy and breastfeeding: Should be avoided during pregnancy and breastfeeding unless specifically recommended by a doctor due to potential risks to the baby
  • Liver impairment: Patients with liver disease may need reduced doses as the drug is processed by the liver
  • Elderly patients: Older adults are more sensitive to zolpidem’s effects and typically require lower doses to reduce fall risk and cognitive impairment

Interactions

Zolpidem can interact with numerous medications and substances:

  • Alcohol: Increases sedation and risk of dangerous sleep behaviors; should be completely avoided
  • Opioid pain medications: Can cause dangerous levels of sedation and respiratory depression
  • Benzodiazepines: Combining with anxiety medications like lorazepam increases sedation risk
  • Antidepressants: Some antidepressants can increase zolpidem blood levels and enhance side effects
  • Antihistamines: Over-the-counter sleep aids and allergy medications can increase drowsiness
  • Rifampin: This antibiotic can reduce zolpidem’s effectiveness by increasing its breakdown
  • Ketoconazole: This antifungal medication can increase zolpidem levels and side effects
  • Cannabis: May increase sedation and impair cognitive function

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the formulation and patient factors. For immediate-release tablets, the usual dose is 5 mg for women and 5-10 mg for men, taken once per night immediately before bedtime. Extended-release formulations are typically prescribed at 6.25 mg for women and 6.25-12.5 mg for men. Elderly patients and those with liver impairment usually receive lower doses. The medication should be taken on an empty stomach for optimal effectiveness, and patients should ensure they have 7-8 hours available for sleep before taking zolpidem. Dosage should always be determined and monitored by a qualified healthcare provider, and the medication should not be taken for longer than prescribed due to dependency risks.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Zolpidem." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/zolpidem/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Magnesium’s hidden role in insulin signalling: why the mineral matters for glucose control

Magnesium acts as a critical molecular switch in insulin signalling. New analysis…

Why the same bread raises blood sugar differently in different people

Researchers at the Weizmann Institute found that identical carbohydrate meals produce glucose…

Vitamin D dose response is not linear: Why shelf-picked supplements may not work as expected

Vitamin D supplements do not work the same way for everyone. Research…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Zopiclone

By
Prof. Giorgi Pkhakadze
02/06/2026

Eszopiclone

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up